AI-generated summary
In this randomized clinical trial, patients with head and neck cancer receiving radiochemotherapy were assigned to photobiomodulation with a preventive oral care protocol alone, or with L-glutamine and hyaluronic acid added. The authors report that the combined group had lower severity of oral mucositis on the WHO scale at the 30th radiotherapy session, but no difference on the NCI scale. Groups were 24 patients each.
- Who or what was studied
- Patients with head and neck cancer undergoing radiochemotherapy
- Limits stated in the abstract
- The benefit appeared on only one of two severity scales, and the abstract reports a small sample of 24 patients per group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Randomized controlled trial, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.